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Abstract. Urolithiasis is one of the most common urologic diseases and it is found more than 3% of 
the population of Russia, which is complicated by calculous pyelonephritis from 43-81% up to 100% 
of cases. The knowledge of the main bacteria usually involved in patients with calculous 
pyelonephritis and their antimicrobial susceptibility is necessary for appropriate empirical therapy and 
prevention of the emergence of antibiotic resistance. The main pathogens in patients with calculous 
pyelonephritis undergoing treatment in the department of urology of St. Joseph Belgorod Regional 
Clinical Hospital in 2013-2015 was Escherichia coli, was presented in 36.8% of the isolates, followed 
by Klebsiella species in 18.1% of the isolates, Enterobacter species in 16.9% of the isolates, and 
Proteus species in 8.8% of the isolates. All isolates showed susceptibilities to carbapenems. Sensitivity 
to cephalosporins ranged from 48.5% of the cases to 41.8% of the cases, to fluoroquinolones from 
32.4% of the cases to 24.5% of the cases, to co-trimoxazole ranged from 27.9% of the cases to 
30.84% of the cases in 2013-2015. It was found increase of aminoglycosides activity: sensitive strains 
to amikacin were allocated 67.6% of the isolates, 86.1% of the isolates, 84.7% of the isolates, it was 
identified sensitive strains to gentamicin in 44.3% of the isolates, 53.5% of the isolates, 55.2% of the 
isolates in 2013, 2014, 2015, respectively. High effective agents was fosfomycin, which shown 
activity in 79.3% of the cases, 84.4% of the cases, 80.4% of the cases in 2013, 2014, 2015, 
respectively. The obtained data were shown, that amikacin, fosfomycin, piperacillin/tazobactam, 
cefoperazone/sulbactam, carbapenems can be used for empirical therapy in patients with calculous 
pyelonephritis undergoing treatment in the department of urology of St. Joseph Belgorod Regional 
Clinical Hospital. 
Keywords: urolithiasis, calculous pyelonephritis, urinary tract infections, antibiotic sensitivity, 
extended-spectrum β-lactamase-producing strains of Enterobacteriacae 
 
Urolithiasis is one of the most common urologic 
diseases and it is found more than 3% of the 
population of Russia [1], which is complicated by 
calculous pyelonephritis from 43-81% up to 100% of 
cases [2]. Currently, despite the relatively well-
studied etiological structure of causative agents of 
pyelonephritis, issues of treatment of this disease is 
still actual, which is associated with the rapid growth 
of pathogens resistant to antimicrobial agents. It has 
transformed rational treatment regimens in the past to 
ineffective [3, 4, 5]. 
Irrational choice of antibacterial agents in 
patients with urinary tract infections not only leads to 
serious medical (increased incidence, recurrence, 
complications) and economic (growth of health care 
costs, increasing the duration of temporary 
disability), but also to the social (the deterioration of 
quality of life) and environmental (growth antibiotic 
resistance of microorganisms) effects [6]. This makes 
it necessary to conduct epidemiological studies to the 
definition of the structure of allocated 
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microorganisms and to determine their sensitivity in 
patients with calculous pyelonephritis. 
Objectives of the study: 
1. To study the structure of pathogens and their 
sensitivity to antibiotics in patients with calculous 
pyelonephritis undergoing treatment in the 
department of urology of St. Joseph Belgorod 
Regional Clinical Hospital in 2013-2015. 
2. To determine the antibacterial 
chemotherapeutic agents for initial and etiological 
antibiotic therapy of patients with calculous 
pyelonephritis in the department of urology of St. 
Joseph Belgorod Regional Clinical Hospital. 
Materials and methods: 
It was a retrospective pharmacoepidemiological 
analysis of medical records.  It were included medical 
history of male and female over 18 years with a 
diagnosis "calculous pyelonephritis" in case samples 
showing significant growth according to criteria 
recommendations of Russian society of urology [7].  
It was analyzed medical history of 736 patients 
(42.2%, of them were men and 57.8% – women; 
mean age of patients was 56.38 ± 6.8 years old) with 
calculous pyelonephritis, who were treated in 
department of urology of St. Joseph Belgorod 
Regional Clinical Hospital in 2013-2015. 
All patients underwent standard clinical 
examination, with mandatory bacteriological urine 
analysis, ultrasound study of kidneys. The clinical 
material for the study was an average portion of the 
morning urine or urine was obtained after drainage of 
the catheter-stent, or the draining ureteral catheter / 
nephrostomy drainage. Samples that were shown 
growth more than one types of organism, or had 
evidence of perineal contamination were not included 
for analysis. 
The identification of microorganisms were 
obtained from the urine of patients with calculous 
pyelonephritis were treated in the department of 
urology of Saint Joseph Belgorod Regional Clinical 
Hospital in 2013-2015. Susceptibility testing was 
done by disk diffusion method and interpreted 
according to the EUCAST criteria. Statistical 
analyses were performed using “Statistica 10.0” 
applied statistical software package.  
Results and discussion. 
During the period of 2013-2015 total 497 strains 
were detected in urine of patients with calculous 
pyelonephritis have being treated in the department 
of urology of Saint Joseph Belgorod Regional 
Clinical Hospital in 2013-2015 (Table 1).  
It was found that the most frequently isolated 
Gram-negative bacteria, were presented by strains of 
Enterobacteriacae. The most common uropathogen 
was Escherichia coli, which was presented in 36.8% 
of the cases, followed by Klebsiella species in 18.1% 
patient of the cases, and Enterobacter species in 
16.9% of the cases. Also it was detected Proteus 
species in 8.8% of the cases, Citrobacter species in 
5.1% of the cases. Pseudomonas species was detected 
in 5.1% of the cases, and Acinetobacter species in   
2.6% of the cases (Table 1). 
Table 1 
Frequency of isolated bacterial pathogens isolated from patients with calculous pyelonephritis in 2013-2015 
 
Pathogens  
Number of isolated strains 
2013 2014  2015  Total  
Acinetobacter spp. 3 2 8 13 
Citrobacter diversus 7 4 14 25 
Escherichia coli. 68 55 60 183 
Enterobacter  spp 34 15 35 84 
Klebsiella spp. 47 28 15 90 
Proteus spp. 14 11 19 44 
Pseudomonas aeruginoza 6 10 9 25 
Enterococcus spp. 8 13 12 33 
Total  187 138 172 497 
 
Among Gram-positive bacteria the most 
frequent Gram-positive pathogen was Enterococcus 
spp. It was identified in 6.5% of the total number of 
strains isolated from urine of patients undergoing 
treatment in with calculous pyelonephritis have being 
treated in the department of urology of Saint Joseph 
Belgorod Regional Clinical Hospital in 2013-2015, 
which is less than the level was obtained by the data 
of other Russian researchers [8].  
Due to the dominance of E. coli and other strains 
of Enterobacteria in the etiological structure of 
pathogens in calculous pyelonephritis the greatest 
interest is the data on the total sensitivity of all 
selected agents Enterobacteriacae and separate data 
sensitivity of E. coli, Klebsiella spp., Enterobacter 
spp. 
Large proportions of E. coli were found to be 
resistant to ampicillin and amoxicillin-clavulanate in 
2013-2015 (Table 2). It amounted 13.6%-18.5% 
susceptible strains and 27.2-33.3% susceptible strains 
to ampicillin and amoxicillin-clavulanate, 
respectively. It was shown high levels of level 
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extended-spectrum beta-lactamase-producing 
Escherichia coli, which reached 40.7% of the 
isolates, 45.5% of the isolates and 45.8% of the 
isolates in 2013, 2014 and 2015, respectively. All 
detected strains have shown their sensitivity to 
carbapenems. 
It was revealed an increase in sensitivity to 
aminoglycosides: in 2013 the sensitivity to amikacin 
and gentamicin amounted to 55.6% of cases and 
51.8% of cases, respectively. In 2014 and 2015, the 
susceptibility to amikacin amounted to 86.4% of the 
cases and 87.5% of the cases, respectively. Activity 
of gentamicin was slightly lower: it was identified in 
63.6% of the strains and 70.8% of the strains in 2014 
and 2015, respectively. 
It was registered the low level of susceptibility 
to fluoroquinolones, which ranged from 31.8% of the 
cases to 37.1% of the cases to ciprofloxacin, from 
29.1% of the cases to 37.1% of cases to levofloxacin 
in 2013-2015. The sensitivity of E. coli to co-
trimoxazole amounted to 37.1% of the isolates, 
36.4% of the isolates, 33.3% of the isolates in 2013, 
2014, 2015, respectively. Fosfomycin showed a high 
level of activity, which was reached to 81.5% of the 
isolates, 86.3% of the isolates and 79.2% of the 
isolates in 2013, 2014 and 2015, respectively. 
The findings suggest about the rise in the level 
of resistance of E. coli to penicillins, cephalosporins, 
fluoroquinolones, which is consistent with domestic 
authors obtained for the years 2009-2013. However, 
the sensitivity E. coli, in patients, who were treated at 
the department of urology of Saint Joseph Belgorod 
Regional Clinical Hospital in 2014-2015, to these 
antibacterial agents retained at substantially high 
sensitivity to amikacin, carbapenems, fosfomycin [8]. 
By comparison the result was obtained in National 
Multicenter Surveillance Study «MARATHON» with 
data of susceptibility to antibiotics in the department 
of urology of St. Joseph Belgorod Regional Clinical 
Hospital revealed higher susceptibility to ampicillin, 
amoxicillin/clavulanate, cephalosporins, 
carbapenems, aminoglycosides, a slightly higher 
susceptibility to fluoroquinolones, co-trimoxazole 
and lower sensitivity to fosfomycin [9].  
As compared with the data of foreign 
researchers, the level of resistance strains of E. coli, 
which were registered in patients with urinary tract 
infections during inpatient treatment, below the level 
of resistance, identified by researchers at the 
Veterans Hospital in Boston (USA), and researchers 
at the hospital of Al Zahra (Iran), but exceeds the 
level of resistance reported in the clinical hospital in 
Dublin (Ireland) [10, 11, 12].  
 
Table 2 
Susceptibility of E. coli, Klebsiella spp., Enterobacter spp. to antibiotics isolated  
from patients with calculous pyelonephritis in 2013-2015 
 
Pathogens 
E. coli Klebsiella spp. Enterobacter spp. 
2013 2014 2015 2013 2014 2015 2013 2014 2015 
Total (%) 29.4 45.9 32 23.53 18.9 10.6 27.45 13.5 21.3 
Ampicillin  18.5 13.6 16.6 0 0 0 0 0 0 
amoxicillin / clavulanate 33.3 27.2 29.1 26.3 18.2 0 0 0 0 
Cefotaxime  59.3 54.5 54.2 36.8 27.3 28.5 46.6 16.6 21.4 
Ceftriaxone  59.3 54.5 54.2 36.8 27.3 28.5 46.6 16.6 21.4 
Ceftazidime 59.3 54.5 54.2 36.8 27.3 28.5 46.6 16.6 21.4 
Cefepime 59.3 59.1 58.3 36.8 36.4 28.5 46.6 16.6 21.4 
Meropenem 100 100 100 100 100 100 100 100 100 
Imipenem 100 100 100 100 100 100 100 100 100 
Ertapenem   100 100 100 100 100 100 100 100 100 
Gentamicin  51.8 63.6 70.8 36.8 45.5 42.8 33.3 33.3 28.5 
Amikacin  55.6 86.4 87.5 73.7 90.9 85.7 73.3 66.6 71.4 
Ciprofloxacin  37.1 31.8 33.3 26.3 18.2 28.5 26.2 16.6 0 
Levofloxacin  37.1 31.8 29.1 26.3 18.2 28.5 20.0 16.6 0 
Co-trimoxazole  37.1 36.4 33.3 21.1 18.2 28.5 26.2 16.6 35.7 
Fosfomycin  81.5 86.3 79.2 73.7 81.8 71.4 86.6 66.6 83.3 
 
Analysis of susceptibility of extended-spectrum 
β-lactamase-producing E.coli were isolated from the 
urine of patients with calculous pyelonephritis which 
were treated in the department of urology of the St. 
Joseph Belgorod Regional Clinical Hospital in 2015 
was registered sensitivity isolates to carbapenem in 
100% of the cases, gentamicin – in 40% of the cases, 
amikacin – in 90% of the cases, to ciprofloxacin – in  
10% of the cases, to levofloxacin – in 10% of the 
cases, to co-trimoxazole – in 10% of the cases, to 
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fosfomycin – in 70% of the cases. The data is 
consistent with British researchers [13].  
Korean researchers have identified slightly higher 
sensitivity of E. coli to the antibiotics: sensitivity to 
ciprofloxacin was identified in 20.7% of the strains, 
levofloxacin – in 22.7% of the strains, amikacin – in 
94.1% of the strains, co-trimoxazole – in  34.3% of the 
strains, fosfomycin – in 87.7% of the strains [14]. 
Isolates of Klebsiella spp. was revealed a high 
level of resistance to penicillins, cephalosporins. All of 
the isolates were found to be resistant to ampicillin. The 
sensitivity to amoxicillin/clavulanate was reduced from 
26.3% in 2013 to 0% of susceptible strains in 2015. 
Number of strains of Klebsiella spp., sensitive to 
cephalosporins was 36.8% in 2013. In 2014-2015 it was 
noted a decrease in their sensitivity to 27.3-28.5%. All 
isolates of Klebsiella spp. showed its sensitivity to 
carbapenems. It was registered low sensitivity to 
fluoroquinolones, co-trimoxazole. It was allocated 
26.3% of the strains, 18.2% of the strains, 28.5% of the 
strains to ciprofloxacin and levofloxacin in 2013, 2014, 
2015, respectively. The level of sensitivity to co-
trimoxazole was 16.6-28.5% of susceptible strains in 
2013-2015, unlike sensitivity to fosfomycin, which was 
73.7%, 81.8%, 71.4% in 2013, 2014, 2015, 
respectively. It was shown low sensitivity to 
gentamicin, which varied from 36.8% to 45.5%, in 
contrast to amikacin, to which sensitivity was 73.7%, 
90.9%, 85.7% in 2013, 2014, 2015, respectively. This is 
consistent with the data of researchers from the United 
States [15], but below the level of resistance was 
identified by Indian researchers. It has been shown, that 
the susceptibility of Klebsiella spp. which were isolated 
from sample of urine of patients who were hospitalized 
in a medical college hospital of Bangalore (India) in 
2012, were registered a lower sensitivity to ampicillin, 
cephalosporins, aminoglycosides, fluoroquinolones. 
The level of sensitivity of strains Klebsiella spp. to 
carbapenems was 67.9% [16].  
In comparison with the result obtained in 
National Multicenter Surveillance Study 
«MARATHON», we found higher sensitivity 
selected strains of Klebsiella spp. to cefotaxime, 
ceftazidime, cefepime, gentamicin, amikacin, with 
comparable susceptibility to carbapenems, 
fluoroquinolones, fosfomycin in the department of 
urology of the Belgorod Regional Clinical Hospital 
of St. Joasaph [9].  
Frequency of the isolated strains of extended-
spectrum β-lactamase-producing Klebsiella spp. 
isolated from the urine of patients with calculous 
pyelonephritis in the urology department of the St. 
Joseph Belgorod Regional Clinical Hospital in 2015 
was reached 71.4% and the isolated strains showed a 
low susceptibility to the test antibiotic compared with 
the registered strains of extended-spectrum β-
lactamase-producing E. coli. It was registered 
sensitivity of isolates Klebsiella spp. to carbapenem 
in 100% of the cases, gentamicin – in 40%  of the 
cases, amikacin – 90% of the cases, to ciprofloxacin 
– in  10% of the cases, to levofloxacin – in 10% of 
the cases, to co-trimoxazole – in 10% of the cases, to 
fosfomycin – in 70% of the cases. The data is 
consistent with Korean researchers. [14].  
Large proportions of the isolates were found to 
be resistant to penicillins and cephalosporins isolated 
strains. All strains of Enterobacter spp. isolated in 
2013-2015 showed their resistance to ampicillin, 
amoxicillin/clavulanate. It was registered increase in 
the level of resistance of Enterobacter spp.: 
sensitivity to cephalosporins was recorded in 46.6% 
of the isolates, 16.6% strains 21.4% of strains in 
2013, 2014, 2015, respectively. Strains of 
Enterobacter spp., which were isolated in 2013-2015, 
have been showed a higher level of resistance to 
cephalosporins as compared with the isolated strains 
of E. coli and Klebsiella spp. All isolates were 
susceptible to carbapenems. Analysis of the 
sensitivity of Enterobacter spp. was established low 
sensitivity to fluoroquinolones, co-trimoxazole. 
Amikacin was active in 73.3% of the cases, 66.6% of 
the cases, 73.3% of the cases; gentamicin in 33.3% of 
the cases, 33.3% of the cases, 28.5% of the cases in 
2013, 2014, 2015, respectively. Susceptibility to 
ciprofloxacin does not exceed 26.2% of the strains to 
levofloxacin – 20.0% of the strains. Selected strains 
of Enterobacter spp. were susceptible to co-
trimoxazole in 26.2% of the cases, 16.6% of the 
cases, 35.7% of the cases in 2013, 2014, 2015, 
respectively. High activity to fosfomycin was showed 
in 86.6% of the isolates, 66.6% of the isolates, 83.3% 
of the isolates in 2013, 2014, 2015, respectively. 
The findings of the high level of resistance 
Enterobacter spp. were consistent with those of 
Russian and foreign authors [9, 17]. 
The identified strains of Enterobacter spp. showed 
the highest level of resistance among 
Enterobacteriaceae. Out of all strains of Enterobacter 
spp. it was registered 78.6% extended-spectrum β-
lactamase-producing strains of Enterobacter spp. in 
patients with calculous pyelonephritis in the department 
of urology of the St. Joseph Belgorod Regional Clinical 
Hospital in 2015. The most active antibacterial agents 
were carbapenems, which sensitivity were 100% of the 
cases. Susceptibility to amoxicillin/clavulanate in 0% of 
the cases, gentamicin – in 27.2% of the cases, amikacin 
– in 63.6% of the cases, ciprofloxacin in 18.2% of the 
cases, levofloxacin – in 9.1% of the cases, co-
trimoxazole – in 0% of the cases, fosfomycin – in 
72.7% of the cases. This data exceeds the level of 
resistance, identified by researchers in the study of the 
spectrum of pathogens and their sensitivity to one of the 
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smaller hospitals in Bo (Sierra Leone) in 2013-2014. 
[18]. 
The most effective agents to all strains of 
isolated Enterobacteriaceae were carbapenems: all 
isolates showed sensitivity to carbapenems. In 
general, the total susceptibilities for all strains of 
Enterobacteriacae were higher compared to strains of 
E. coli and below compared to strains of Klebsiella 
spp. and Enterobacter spp. Sensitivity to ampicillin 
was 7.5% of the cases, 9.3% of the cases, 11.3% of 
the cases; amoxicillin/clavulanate – 23.0% of the 
cases, 23.2% of the cases, 17.0% of cases, 
cefotaxime, ceftriaxone, and ceftazidime – 48.5% of 
the cases, 41.8% of the cases, 41.9% of the cases, to 
the cefepime – 48.5% of the cases, 46.5% of the 
cases, 43.8% of the cases in 2013, 2014, 2015, 
respectively. Fluoroquinolones activity was as 
follows: 32.4% of the cases, 30.2% of the cases, 
26.4% of the cases to ciprofloxacin, 31.1% of the 
cases, 30.2% of the cases, 24.5% for the cases to 
levofloxacin; in 2013, 2014, 2015, respectively. 
Sensitivity to co-trimoxazole ranged from 27.9% of 
the cases to 30.84% of the cases in 2013-2015. 
Aminoglycosides showed an increase of its activity: 
sensitive strains to amikacin were allocated 67.6% of 
the isolates, 86.1% of the isolates, 84.7% of the 
isolates in 2013, 2014, 2015, respectively. It was 
registered lower sensitivity to gentamicin compared 
to amikacin. It identified 44.3% of the isolates, 
53.5% of the isolates, 55.2% of the isolates sensitive 
to gentamicin in 2013, 2014, 2015, respectively. High 
effective agents was fosfomycin, which was active in 
79.3% of the cases, 84.4% of the cases, 80.4% of the 
cases in 2013, 2014, 2015, respectively. 
Summary: 
1. The main pathogens in patients with calculous 
pyelonephritis undergoing in-patient treatment in the 
department of urology of St. Joseph Belgorod 
Regional Clinical Hospital in 2013-2015 was 
Escherichia coli, was presented in 36.8% of the 
isolates, followed by Klebsiella species in 18.1% of 
the isolates, Enterobacter species in 16.9% of the 
isolates, and Proteus species in 8.8% of the isolates. 
All isolates showed susceptibilities to carbapenems. 
Sensitivity to cephalosporins ranged from 48.5% of 
the cases to 41.8% of the cases, to fluoroquinolones 
from 32.4% of the cases to 24.5% of the cases, to co-
trimoxazole ranged from 27.9% of the cases to 
30.84% of the cases in 2013-2015. It was found 
increase of aminoglycosides activity: sensitive strains 
to amikacin was allocated 67.6% of the isolates, 
86.1% of the isolates, 84.7% of the isolates, it were 
identified sensitive strains to gentamicin in 44.3% of 
the isolates, 53.5% of the isolates, 55.2% of the 
isolates in 2013, 2014, 2015, respectively. High 
effective agents was fosfomycin, which shown 
activity in 79.3% of cases, 84.4% of cases, 80.4% of 
cases in 2013, 2014, 2015, respectively.  
2. For initial antibiotic therapy of calculous 
pyelonephritis patients in patients undergoing 
treatment in the department of urology of St. Joseph 
Belgorod Regional Clinical Hospital is recommended 
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